Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 25, 2023
What's new in prostate cancer: 5 takeaways
‘Many reasons for optimism’ says expert at annual community symposium
'Bipolar' therapy: Treating advanced prostate cancer with high-dose testosterone
Men with a certain type of aggressive prostate cancer may benefit from therapy that cycles hormones through high peaks and low valleys, small study finds
Intermittent hormone therapy for prostate cancer inferior to continuous therapy
Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival
Two Center scientists receive new investigator awards
Bielas, Mostaghel secure three-year funding for prostate-cancer research
Uncovering the path to therapy resistance in prostate tumors
Research explains how advanced prostate cancer becomes resistant to androgen-deprivation therapy; findings suggest androgen production occurs within metastatic prostate tumors
Research explains how advanced prostate cancer becomes resistant to androgen-deprivation therapy
Findings suggest androgen production occurs within metastatic prostate tumors
TRT treatment for male menopause
Researchers find prostate gland may be capable of buffering negative effects of testosterone-replacement therapy